| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 62.4428 | 66 |
| GSM780708 | Untreated after 4 days (C2_1) | 63.8589 | 67 |
| GSM780709 | Untreated after 4 days (C3_1) | 53.3419 | 57 |
| GSM780719 | Untreated after 4 days (C1_2) | 62.0216 | 66 |
| GSM780720 | Untreated after 4 days (C2_2) | 57.4509 | 62 |
| GSM780721 | Untreated after 4 days (C3_2) | 52.7986 | 56 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 52.9307 | 56 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 58.8572 | 64 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 63.6224 | 67 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 62.5741 | 66 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.5652 | 30 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 58.2339 | 63 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 58.5689 | 63 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 62.7093 | 66 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 56.8567 | 62 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 58.4036 | 63 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 64.9097 | 67 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 61.9644 | 66 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 57.4306 | 62 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 68.5385 | 69 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 62.4052 | 66 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 62.0296 | 66 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 53.7147 | 57 |